公开(公告)号：US20190091272A1

公开(公告)日：2019-03-28

申请号：US16200344

申请日：2018-11-26

Applicant: Ching-Hua Su ,  Cheng-Jeng Tai ,  Taiwan Indigena Botanica Co., Ltd.

Inventor： Ching-Hua Su ,  Cheng-Jeng Tai

IPC: A61K36/074 ,  A61K31/7048

Abstract: An anti-cancer drug composition includes a Ganoderma extract having a concentration of 1-5 mg/ml and an amphotericin B having a concentration of 3-10 μM. The Ganoderma extract and the amphotericin B are medicated at different times by pre-treating cancer cells with the Ganoderma extract for a period of time followed by administration of the amphotericin B to enhance an anti-cancer effect of the amphotericin B.

公开(公告)号：US20170056460A1

公开(公告)日：2017-03-02

申请号：US15044794

申请日：2016-02-16

Applicant: Ching-Hua Su ,  Cheng-Jeng Tai ,  Taiwan Indigena Botanica Co., Ltd.

Inventor： Ching-Hua Su ,  Cheng-Jeng Tai

IPC: A61K36/074 ,  A61K31/7048

CPC classification number: A61K36/074 ,  A61K31/7048 ,  A61K2300/00

Abstract: An anti-cancer drug composition includes a Ganoderma extract having a concentration of 1-5 mg/ml and an amphotericin B having a concentration of 3-10 μM. The Ganoderma extract and the amphotericin B are medicated at different times by pre-treating cancer cells with the Ganoderma extract for a period of time followed by administration of the amphotericin B to enhance an anti-cancer effect of the amphotericin B.

Abstract translation: 抗癌药物组合物包括浓度为1-5mg / ml的灵芝提取物和浓度为3-10μM的两性霉素B。 灵芝提取物和两性霉素B通过用灵芝提取物预处理癌细胞一段时间，然后施用两性霉素B以增强两性霉素B的抗癌作用，在不同时间进行药物治疗。